Evidence map›Paper›PMID 38622544›Full record

ArticleBMC pregnancy and childbirth2024

Epidemiological and virological surveillance of the prevention of mother-to-child transmission of HIV among pregnant women in Togo.

Kokou Tegueni, Fifonsi Adjidossi Gbeasor-Komlanvi, Oumarou I Wone Adama, Arnold Junior Sadio, Amivi Phyllis Amenyah-Ehlan, Claver Anoumou Dagnra, Didier Koumavi Ekouevi

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Kokou TegueniDépartement des Sciences Fondamentales, Laboratoire de Biologie Moléculaire et d'Immunologie (BIOLIM- FSS/UL), Université de Lomé, Lomé, Togo.
Fifonsi Adjidossi Gbeasor-KomlanviDépartement de Santé Publique, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Oumarou I Wone AdamaDépartement de Santé Publique, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Arnold Junior SadioDépartement de Santé Publique, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Amivi Phyllis Amenyah-EhlanDépartement des Sciences Fondamentales, Laboratoire de Biologie Moléculaire et d'Immunologie (BIOLIM- FSS/UL), Université de Lomé, Lomé, Togo.
Claver Anoumou DagnraDépartement des Sciences Fondamentales, Laboratoire de Biologie Moléculaire et d'Immunologie (BIOLIM- FSS/UL), Université de Lomé, Lomé, Togo.
Didier Koumavi EkoueviDépartement de Santé Publique, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo. didier.ekouevi@gmail.com.
University of Lomé · TGLaboratoire National de Référence · MAInstitut de Recherche pour le Développement · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2015, Togo introduced the "test-and-treat" strategy for the prevention of mother-to-child transmission (PMTCT) of HIV. Pediatric HIV infection remains a public health problem in Togo, with a mother-to-child transmission (MTCT) rate of 3.6% in 2020. This study aimed to estimate cases of HIV seroconversion during pregnancy and to identify pregnant women at high risk of transmitting HIV to their children in Lomé, Togo.

methodsA descriptive cross-sectional study was carried out from 18 March to 22 May 2022 among women who had given birth in five maternity units providing PMTCT services in Lomé. Umbilical cord blood samples were taken from the maternal side by midwives after delivery. HIV serology was performed in the laboratory using the Alere™ HIV Combo SET and First Response HIV 1-2. Card Test version 2.0. A sample was considered positive if both tests were positive. The HIV-1 viral load in HIV-1-positive samples was measured using Cobas/Roche 4800 equipment. Information on the women was extracted from maternal antenatal records and antenatal consultation registers.

resultsA total of 3148 umbilical cord blood samples (median maternal age: 28 years (interquartile range [24-32]) were collected. Among them, 99.3% (3145/3148) had presented for at least one antenatal clinic visit before giving birth, and 78.7% (2456/3122) had presented for at least four visits. One hundred and twenty-one (121) cord samples were HIV-1 positive, representing a seroprevalence of 3.8% (95% CI = [3.2-4.6]). Among them, 67.8% (82/121) were known HIV-positive before the current pregnancy, 29.7 (36/121) were diagnosed as HIV-positive at the antenatal visits and 2.5% (3/121) were diagnosed as HIV-positive in the delivery room. Of the HIV-positive women, 85.9% (104/121) were on ARV treatment before delivery. The viral load was < 1000 copies/ml in 97.5% (118/121) cases.

conclusionThis study explored the virologic and epidemiological aspects of HIV among pregnant women in Togo. The results show significant viral suppression at delivery in women ART. Surveillance based on umbilical cord blood specimen screening is an interesting approach for monitoring the effectiveness of PMTCT programmes.

Indexed as

HIV-1HIV InfectionsHIV SeropositivityPregnancy Complications, InfectiousAdultCross-Sectional StudiesFemaleHumansInfectious Disease Transmission, VerticalPregnancyPregnant PeopleSeroepidemiologic StudiesTogoHIVMother-to child transmissionTogoViral load

Identifiers

PMID38622544
PMCPMC11017652
OpenAlexW4394813325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.